Characterization of novel monoclonal antibodies against the MERS-coronavirus spike protein and their application in species-independent antibody detection by competitive ELISA

Journal of Virological Methods

Volumn 251, Issue , 2018, Pages 22-29

  Fukushi, Shuetsu ^a   Fukuma, Aiko ^a   Kurosu, Takeshi ^a   Watanabe, Shumpei ^a   Shimojima, Masayuki ^a   Shirato, Kazuya ^a   Iwata Yoshikawa, Naoko ^a   Nagata, Noriyo ^a   Ohnishi, Kazuo ^a   Ato, Manabu ^a   Melaku, Simenew Keskes ^b   Sentsui, Hiroshi ^c   Saijo, Masayuki ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b ADDIS ABABA SCIENCE AND TECHNOLOGY UNIVERSITY   (Ethiopia)

^c NIHON UNIVERSITY   (Japan)

Author keywords

Competitive ELISA; Epidemiology; MERS coronavirus; Neutralizing antibody

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; VIRUS SPIKE PROTEIN; CORONAVIRUS SPIKE GLYCOPROTEIN; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DROMEDARY; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHIOPIA; LEPORIDAE; MEASUREMENT ACCURACY; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIVITY AND SPECIFICITY; VIRUS NEUTRALIZATION; ANIMAL; BLOOD; CAMEL; IMMUNOLOGY; ISOLATION AND PURIFICATION; PROCEDURES; VALIDATION STUDY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; CAMELUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; RABBITS; RATS; SENSITIVITY AND SPECIFICITY; SPIKE GLYCOPROTEIN, CORONAVIRUS;

EID: 85030857994     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2017.10.008     Document Type: Article

References (33)

1. Al Hammadi, Z.M., Chu, D.K., Eltahir, Y.M., Al Hosani, F., Al Mulla, M., Tarnini, W., Hall, A.J., Perera, R.A., Abdelkhalek, M.M., Peiris, J.S., Al Muhairi, S.S., Poon, L.L., Asymptomatic MERS-CoV infection in humans possibly linked to infected dromedaries imported from Oman to United Arab Emirates, May 2015. Emerg. Infect. Dis. 21 (2015), 2197–2200.
2. Al-Gethamy, M., Corman, V.M., Hussain, R., Al-Tawfiq, J.A., Drosten, C., Memish, Z.A., A case of long-term excretion and subclinical infection with Middle East respiratory syndrome coronavirus in a healthcare worker. Clin. Infect. Dis. 60 (2015), 973–974.
3. Blomstrom, A.L., Scharin, I., Stenberg, H., Figueiredo, J., Nhambirre, O., Abilio, A., Berg, M., Fafetine, J., Seroprevalence of Rift Valley fever virus in sheep and goats in Zambezia, Mozambique. Infect. Ecol. Epidemiol., 6, 2016, 31343.
4. Chand, K., Biswas, S.K., Pandey, A.B., Saxena, A., Tewari, N., Mondal, B., A competitive ELISA for detection of group specific antibody to bluetongue virus using anti-core antibody. Biologicals 46 (2017), 168–171.
5. Chen, Y., Chan, K.H., Kang, Y., Chen, H., Luk, H.K., Poon, R.W., Chan, J.F., Yuen, K.Y., Xia, N., Lau, S.K., Woo, P.C., A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus. Emerg. Microbes Infect., 4, 2015, e26.
6. Corman, V.M., Eckerle, I., Bleicker, T., Zaki, A., Landt, O., Eschbach-Bludau, M., van Boheemen, S., Gopal, R., Ballhause, M., Bestebroer, T.M., Muth, D., Muller, M.A., Drexler, J.F., Zambon, M., Osterhaus, A.D., Fouchier, R.M., Drosten, C., Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill., 17, 2012.
7. Drosten, C., Meyer, B., Muller, M.A., Corman, V.M., Al-Masri, M., Hossain, R., Madani, H., Sieberg, A., Bosch, B.J., Lattwein, E., Alhakeem, R.F., Assiri, A.M., Hajomar, W., Albarrak, A.M., Al-Tawfiq, J.A., Zumla, A.I., Memish, Z.A., Transmission of MERS-coronavirus in household contacts. New Engl. J. Med. 371 (2014), 828–835.
8. Fukuma, A., Tani, H., Taniguchi, S., Shimojima, M., Saijo, M., Fukushi, S., Inability of rat DPP4 to allow MERS-CoV infection revealed by using a VSV pseudotype bearing truncated MERS-CoV spike protein. Arch. Virol. 160 (2015), 2293–2300.
9. Fukuma, A., Fukushi, S., Yoshikawa, T., Tani, H., Taniguchi, S., Kurosu, T., Egawa, K., Suda, Y., Singh, H., Nomachi, T., Gokuden, M., Ando, K., Kida, K., Kan, M., Kato, N., Yoshikawa, A., Kitamoto, H., Sato, Y., Suzuki, T., Hasegawa, H., Morikawa, S., Shimojima, M., Saijo, M., Severe fever with thrombocytopenia syndrome virus antigen detection using monoclonal antibodies to the nucleocapsid protein. PLoS Negl. Trop. Dis., 10, 2016, e0004595.
10. Fukushi, S., Mizutani, T., Saijo, M., Matsuyama, S., Miyajima, N., Taguchi, F., Itamura, S., Kurane, I., Morikawa, S., Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein. J. Gen. Virol. 86 (2005), 2269–2274.
11. Fukushi, S., Mizutani, T., Saijo, M., Kurane, I., Taguchi, F., Tashiro, M., Morikawa, S., Evaluation of a novel vesicular stomatitis virus pseudotype-based assay for detection of neutralizing antibody responses to SARS-CoV. J. Med. Virol. 78 (2006), 1509–1512.
12. Hemida, M.G., Perera, R.A., Al Jassim, R.A., Kayali, G., Siu, L.Y., Wang, P., Chu, K.W., Perlman, S., Ali, M.A., Alnaeem, A., Guan, Y., Poon, L.L., Saif, L., Peiris, M., Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity. Euro Surveill., 19, 2014.
13. Hirota, J., Shimoji, Y., Shimizu, S., New sensitive competitive enzyme-linked immunosorbent assay using a monoclonal antibody against nonstructural protein 1 of West Nile virus NY99. Clin. Vaccine Immunol. 19 (2012), 277–283.
14. Houlihan, C.F., McGowan, C.R., Dicks, S., Baguelin, M., Moore, D.A.J., Mabey, D., Roberts, C.H., Kumar, A., Samuel, D., Tedder, R., Glynn, J.R., Ebola exposure, illness experience, and Ebola antibody prevalence in international responders to the West African Ebola epidemic 2014–2016: A cross-sectional study. PLoS Med., 14, 2017, e1002300.
15. Ishii, K., Hasegawa, H., Nagata, N., Ami, Y., Fukushi, S., Taguchi, F., Tsunetsugu-Yokota, Y., Neutralizing antibody against severe acute respiratory syndrome (SARS)-coronavirus spike is highly effective for the protection of mice in the murine SARS model. Microbiol. Immunol. 53 (2009), 75–82.
16. Iwata-Yoshikawa, N., Fukushi, S., Fukuma, A., Suzuki, T., Takeda, M., Tashiro, M., Hasegawa, H., Nagata, N., Non susceptibility of neonatal and adult rats against the middle east respiratory syndrome Coronavirus. Jpn. J. Infect. Dis. 69 (2016), 510–516.
17. Lu, G., Liu, D., SARS-like virus in the Middle East: a truly bat-related coronavirus causing human diseases. Protein Cell. 3 (2012), 803–805.
18. Memish, Z.A., Al-Tawfiq, J.A., Makhdoom, H.Q., Al-Rabeeah, A.A., Assiri, A., Alhakeem, R.F., AlRabiah, F.A., Al Hajjar, S., Albarrak, A., Flemban, H., Balkhy, H., Barry, M., Alhassan, S., Alsubaie, S., Zumla, A., Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study. Clin. Microbiol. Infect. 20 (2014), 469–474.
19. Meyer, B., Drosten, C., Muller, M.A., Serological assays for emerging coronaviruses: challenges and pitfalls. Virus Res. 194 (2014), 175–183.
20. Moreno, A., Lelli, D., Brocchi, E., Sozzi, E., Vinco, L.J., Grilli, G., Cordioli, P., Monoclonal antibody-based ELISA for detection of antibodies against H5 avian influenza viruses. J. Virol. Methods 187 (2013), 424–430.
21. Muller, M.A., Meyer, B., Corman, V.M., Al-Masri, M., Turkestani, A., Ritz, D., Sieberg, A., Aldabbagh, S., Bosch, B.J., Lattwein, E., Alhakeem, R.F., Assiri, A.M., Albarrak, A.M., Al-Shangiti, A.M., Al-Tawfiq, J.A., Wikramaratna, P., Alrabeeah, A.A., Drosten, C., Memish, Z.A., Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect. Dis., 15, 2015, 629.
22. Perera, R.A., Wang, P., Gomaa, M.R., El-Shesheny, R., Kandeil, A., Bagato, O., Siu, L.Y., Shehata, M.M., Kayed, A.S., Moatasim, Y., Li, M., Poon, L.L., Guan, Y., Webby, R.J., Ali, M.A., Peiris, J.S., Kayali, G., Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill., 18, 2013, 20574 pii = 20574.
23. Qing, T., Saijo, M., Lei, H., Niikura, M., Maeda, A., Ikegami, T., Xinjung, W., Kurane, I., Morikawa, S., Detection of immunoglobulin G to Crimean-Congo hemorrhagic fever virus in sheep sera by recombinant nucleoprotein-based enzyme-linked immunosorbent and immunofluorescence assays. J. Virol. Methods 108 (2003), 111–116.
24. Reusken, C., Mou, H., Godeke, G.J., van der Hoek, L., Meyer, B., Muller, M.A., Haagmans, B., de Sousa, R., Schuurman, N., Dittmer, U., Rottier, P., Osterhaus, A., Drosten, C., Bosch, B.J., Koopmans, M., Specific serology for emerging human coronaviruses by protein microarray. Euro Surveill., 18, 2013, 20441.
25. Reusken, C.B., Haagmans, B.L., Muller, M.A., Gutierrez, C., Godeke, G.J., Meyer, B., Muth, D., Raj, V.S., Smits-De Vries, L., Corman, V.M., Drexler, J.F., Smits, S.L., El Tahir, Y.E., De Sousa, R., van Beek, J., Nowotny, N., van Maanen, K., Hidalgo-Hermoso, E., Bosch, B.J., Rottier, P., Osterhaus, A., Gortazar-Schmidt, C., Drosten, C., Koopmans, M.P., Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect. Dis. 13 (2013), 859–866.
26. Reusken, C.B., Messadi, L., Feyisa, A., Ularamu, H., Godeke, G.J., Danmarwa, A., Dawo, F., Jemli, M., Melaku, S., Shamaki, D., Woma, Y., Wungak, Y., Gebremedhin, E.Z., Zutt, I., Bosch, B.J., Haagmans, B.L., Koopmans, M.P., Geographic distribution of MERS coronavirus among dromedary camels, Africa. Emerg. Infect. Dis. 20 (2014), 1370–1374.
27. Shirato, K., Azumano, A., Nakao, T., Hagihara, D., Ishida, M., Tamai, K., Yamazaki, K., Kawase, M., Okamoto, Y., Kawakami, S., Okada, N., Fukushima, K., Nakajima, K., Matsuyama, S., Middle East respiratory syndrome coronavirus infection not found in camels in Japan. Jpn. J. Infect. Dis. 68 (2015), 256–258.
28. WHO. 2017. http://www.who.int/emergencies/mers-cov/en/.
29. Wang, N., Shi, X., Jiang, L., Zhang, S., Wang, D., Tong, P., Guo, D., Fu, L., Cui, Y., Liu, X., Arledge, K.C., Chen, Y.H., Zhang, L., Wang, X., Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell. Res. 23 (2013), 986–993.
30. Who Mers-Cov Research, G., State of knowledge and data gaps of middle east respiratory syndrome Coronavirus (MERS-CoV) in humans. PLoS Curr., 5, 2013.
31. Ying, T., Prabakaran, P., Du, L., Shi, W., Feng, Y., Wang, Y., Wang, L., Li, W., Jiang, S., Dimitrov, D.S., Zhou, T., Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody. Nat. Commun., 6, 2015, 8223.
32. Zaki, A.M., van Boheemen, S., Bestebroer, T.M., Osterhaus, A.D., Fouchier, R.A., Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 367 (2012), 1814–1820.
33. de Groot, R.J., Baker, S.C., Baric, R.S., Brown, C.S., Drosten, C., Enjuanes, L., Fouchier, R.A., Galiano, M., Gorbalenya, A.E., Memish, Z.A., Perlman, S., Poon, L.L., Snijder, E.J., Stephens, G.M., Woo, P.C., Zaki, A.M., Zambon, M., Ziebuhr, J., Middle east respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus study group. J. Virol. 87 (2013), 7790–7792.